An Israeli firm deriving medicines from cannabis listed shares on the London Stock Exchange this week, despite UK laws in the field lagging behind other countries.
MGC Pharmaceuticals issued £6.5 million shares in the British capital, having already listed in Australia, as it eyes the European, North American, and Australasian markets.
Cannabis based products for medicinal use contain cannabinoids derived from the cannabis plant. These include tetrahydrocannabinol (THC) and cannabidiol (CBD).
Synthetic cannabinoids for medicinal use typically mimic the effects of specific cannabinoids such THC, which is the constituent of cannabis that causes the ‘high’. CBD, by contrast, is not intoxicating at typical doses.
From November 2018, some unlicensed cannabis-based products were allowed to be prescribed for the first time in the UK, but only by doctors on the relevant Specialist Register of the General Medical Council.
They are currently used to treat chronic pain, some treatment resistant epilepsies, and nausea and vomiting caused by chemotherapy.
MGC Pharma focuses on phytocannabinoid derived medicines used to treat some cancers, neurological conditions, and auto-immune diseases. It also produces ArtemiC, which is being used to treat Covid-19 infected patients.
Thank you for helping to make Jewish News the leading source of news and opinion for the UK Jewish community. Today we're asking for your invaluable help to continue putting our community first in everything we do.
Unlike other Jewish media, we do not charge for content. That won’t change. Because we are free, we rely on advertising to cover our costs. This vital lifeline, which has dropped in recent years, has fallen further due to coronavirus.
For as little as £5 a month you can help sustain the vital work we do in celebrating and standing up for Jewish life in Britain.
Jewish News holds our community together and keeps us connected. Like a synagogue, it’s where people turn to feel part of something bigger. It also proudly shows the rest of Britain the vibrancy and rich culture of modern Jewish life.
You can make a quick and easy one-off or monthly contribution of £5, £10, £20 or any other sum you’re comfortable with.
100% of your donation will help us continue celebrating our community, in all its dynamic diversity...
Being a community platform means so much more than producing a newspaper and website. One of our proudest roles is media partnering with our invaluable charities to amplify the outstanding work they do to help us all.
There’s no shortage of oys in the world but Jewish News takes every opportunity to celebrate the joys too, through projects like Night of Heroes, 40 Under 40 and other compelling countdowns that make the community kvell with pride.
In the first collaboration between media outlets from different faiths, Jewish News worked with British Muslim TV and Church Times to produce a list of young activists leading the way on interfaith understanding.
Royal Mail issued a stamp honouring Holocaust hero Sir Nicholas Winton after a Jewish News campaign attracted more than 100,000 backers. Jewish News also produces special editions of the paper highlighting pressing issues including mental health and Holocaust remembrance.
In an age when news is readily accessible, Jewish News provides high-quality content free online and offline, removing any financial barriers to connecting people.
Voice of our community to wider society
The Jewish News team regularly appears on TV, radio and on the pages of the national press to comment on stories about the Jewish community. Easy access to the paper on the streets of London also means Jewish News provides an invaluable window into the community for the country at large.
We hope you agree all this is worth preserving.